Management of low- and intermediate-risk prostate cancer

被引：0
|
作者：
Henk van der Poel
Laurence Klotz
Christian G. Stief
机构：
[1] Netherlands Cancer Institute,Department of Urology
[2] Sunnybrook Health Sciences Centre,Department of Urology
[3] Ludwig-Maximilians-Universität München,undefined
来源：
World Journal of Urology | 2015年 / 33卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：905 / 906
页数：1
相关论文
共 50 条
  • [1] Management of low- and intermediate-risk prostate cancer
    van der Poel, Henk
    Klotz, Laurence
    Stief, Christian G.
    [J]. WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 905 - 906
  • [2] Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer
    Kishan, Amar U.
    King, Christopher R.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2017, 27 (03) : 268 - 278
  • [3] Longitudinal regret after treatment for low- and intermediate-risk prostate cancer
    Hurwitz, Lauren M.
    Cullen, Jennifer
    Kim, Daniel J.
    Elsamanoudi, Sally
    Hudak, Jane
    Colston, Maryellen
    Travis, Judith
    Kuo, Huai-Ching
    Rice, Kevin R.
    Porter, Christopher R.
    Rosner, Inger L.
    [J]. CANCER, 2017, 123 (21) : 4252 - 4258
  • [4] Pure Hypofractionated Radiotherapy for the Treatment of Low- to Intermediate-Risk Prostate Cancer
    Stephens, R.
    Gopaul, D.
    Panjwani, D.
    Lock, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S732 - S732
  • [5] Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
    Kunogi, Hiroaki
    Wakumoto, Yoshiaki
    Kawamoto, Terufumi
    Oshima, Masaki
    Horie, Shigeo
    Sasai, Keisuke
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (06) : 554 - 561
  • [6] Metastasis and Mortality in Men With Low- and Intermediate-Risk Prostate Cancer on Active Surveillance
    Courtney, P. Travis
    Deka, Rishi
    Kotha, Nikhil, V
    Cherry, Daniel R.
    Salans, Mia A.
    Nelson, Tyler J.
    Kumar, Abhishek
    Luterstein, Elaine
    Yip, Anthony T.
    Nalawade, Vinit
    Parsons, J. Kellogg
    Kader, A. Karim
    Stewart, Tyler F.
    Rose, Brent S.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (02): : 151 - +
  • [7] SBRT in low- and intermediate-risk prostate cancer: results of a phase II study
    D'Agostino, G.
    Villa, E.
    Franzese, C.
    Liardo, R.
    Reggiori, G.
    Navarria, P.
    Iftode, C.
    De Rose, F.
    Franceschini, D.
    Tozzi, A.
    Comito, T.
    Ascolese, A.
    Tomatis, S.
    Scorsetti, M.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S628 - S629
  • [8] Tissue Phenomics for prognostic biomarker discovery in low- and intermediate-risk prostate cancer
    Harder, Nathalie
    Athelogou, Maria
    Hessel, Harald
    Brieu, Nicolas
    Yigitsoy, Mehmet
    Zimmermann, Johannes
    Baatz, Martin
    Buchner, Alexander
    Stief, Christian G.
    Kirchner, Thomas
    Binnig, Gerd
    Schmidt, Guenter
    Huss, Ralf
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [9] INTRADUCTAL CARCINOMA IN LOW- AND INTERMEDIATE-RISK PROSTATE CANCER: PATHOLOGICAL AND CLINICAL RELEVANCE
    Chiacchio, Giuseppe
    Dell'Atti, Lucio
    Palagonia, Erika
    Cicconofri, Andrea
    Parlavecchio, Arnaldo
    Franzese, Carmine
    Pitoni, Lucia
    Castellani, Daniele
    Cimadamore, Alessia
    Montironi, Rodolfo
    Milanese, Giulio
    Galosi, Andrea Benedetto
    [J]. ANTICANCER RESEARCH, 2021, 41 (10) : 5316 - 5318
  • [10] Testosterone kinetics after proton therapy for low- and intermediate-risk prostate cancer
    Nichols, Romaine Charles
    Morris, Christopher G.
    Hoppe, Bradford S.
    Henderson, Randal H.
    Mendenhall, William M.
    Li, Zuofeng
    Williams, Christopher R.
    Costa, Joseph A.
    Harris, Stephanie
    Mendenhall, Nancy Price
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
12345